These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 25266282)
1. Potential avoidance of adverse analgesic effects using a biologically "smart" hydrogel capable of controlled bupivacaine release. Taraballi F; Minardi S; Corradetti B; Yazdi IK; Balliano MA; Van Eps JL; Allegri M; Tasciotti E J Pharm Sci; 2014 Nov; 103(11):3724-3732. PubMed ID: 25266282 [TBL] [Abstract][Full Text] [Related]
2. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release. Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022 [TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique. Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445 [TBL] [Abstract][Full Text] [Related]
5. Spatiotemporal Programing for the On-Demand Release of Bupivacaine Based on an Injectable Composite Hydrogel. Dinh VV; Suh YS; Yang HK; Lim YT J Pharm Sci; 2016 Dec; 105(12):3634-3644. PubMed ID: 27789030 [TBL] [Abstract][Full Text] [Related]
6. Local anesthetic effects of bupivacaine loaded lipid-polymer hybrid nanoparticles: In vitro and in vivo evaluation. Ma P; Li T; Xing H; Wang S; Sun Y; Sheng X; Wang K Biomed Pharmacother; 2017 May; 89():689-695. PubMed ID: 28267672 [TBL] [Abstract][Full Text] [Related]
7. PLGA microparticle-embedded thermosensitive hydrogels for sustained release of hydrophobic drugs. Joung YK; Choi JH; Park KM; Park KD Biomed Mater; 2007 Dec; 2(4):269-73. PubMed ID: 18458485 [TBL] [Abstract][Full Text] [Related]
8. Tracking the in vivo release of bioactive NRG from PLGA and PEG-PLGA microparticles in infarcted hearts. Pascual-Gil S; Simón-Yarza T; Garbayo E; Prosper F; Blanco-Prieto MJ J Control Release; 2015 Dec; 220(Pt A):388-396. PubMed ID: 26546270 [TBL] [Abstract][Full Text] [Related]
9. Design and optimization of NSAID loaded nanoparticles. Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573 [TBL] [Abstract][Full Text] [Related]
10. PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors. Parajó Y; d'Angelo I; Horváth A; Vantus T; György K; Welle A; Garcia-Fuentes M; Alonso MJ Eur J Pharm Sci; 2010 Dec; 41(5):644-9. PubMed ID: 20869438 [TBL] [Abstract][Full Text] [Related]
11. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles. Keohane K; Brennan D; Galvin P; Griffin BT Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950 [TBL] [Abstract][Full Text] [Related]
12. Compared in vivo toxicity in mice of lung delivered biodegradable and non-biodegradable nanoparticles. Aragao-Santiago L; Hillaireau H; Grabowski N; Mura S; Nascimento TL; Dufort S; Coll JL; Tsapis N; Fattal E Nanotoxicology; 2016; 10(3):292-302. PubMed ID: 26573338 [TBL] [Abstract][Full Text] [Related]
13. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan. Li Z; Xiong F; He J; Dai X; Wang G Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030 [TBL] [Abstract][Full Text] [Related]
14. Sustainable release of vancomycin, gentamicin and lidocaine from novel electrospun sandwich-structured PLGA/collagen nanofibrous membranes. Chen DW; Hsu YH; Liao JY; Liu SJ; Chen JK; Ueng SW Int J Pharm; 2012 Jul; 430(1-2):335-41. PubMed ID: 22521880 [TBL] [Abstract][Full Text] [Related]
15. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations. Salama AH; Mahmoud AA; Kamel R AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410 [TBL] [Abstract][Full Text] [Related]
16. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles. Klose D; Delplace C; Siepmann J Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644 [TBL] [Abstract][Full Text] [Related]
17. Sciatic nerve blockade with lipid-protein-sugar particles containing bupivacaine. Kohane DS; Lipp M; Kinney RC; Lotan N; Langer R Pharm Res; 2000 Oct; 17(10):1243-9. PubMed ID: 11145230 [TBL] [Abstract][Full Text] [Related]
18. Inhalable DNase I microparticles engineered with biologically active excipients. Osman R; Al Jamal KT; Kan PL; Awad G; Mortada N; El-Shamy AE; Alpar O Pulm Pharmacol Ther; 2013 Dec; 26(6):700-9. PubMed ID: 23933140 [TBL] [Abstract][Full Text] [Related]
19. Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles. Manca ML; Loy G; Zaru M; Fadda AM; Antimisiaris SG Colloids Surf B Biointerfaces; 2008 Dec; 67(2):166-70. PubMed ID: 18835764 [TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery. Feng R; Zhang Z; Li Z; Huang G Drug Deliv; 2014 May; 21(3):185-92. PubMed ID: 24107001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]